Black Rock Inc. Coh Bar, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.17 - $5.25 $45,320 - $1.4 Million	-266,591 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$0.17 - $0.34 $20,369 - $40,739	-119,822 Reduced 31.01%	266,591 $51,000
Q1 2022 May 12, 2022	SELL	$0.25 - $0.43 $987 - $1,698	-3,951 Reduced 1.01%	386,413 $121,000
Q4 2021 Feb 10, 2022	BUY	$0.34 - $1.0 $13,701 - $40,298	40,298 Added 11.51%	390,364 $136,000
Q3 2021 Nov 09, 2021	BUY	$0.96 - $1.62 $8,487 - $14,322	8,841 Added 2.59%	350,066 $336,000

Q2 2021 Aug 11, 2021	BUY	$1.09 - $1.49 $371,935 - $508,425	341,225 New	341,225 $478,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $2.35M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.